Mortality Prediction in the elderly patients with Coronary Artery Disease and Atrial Fibrillation: A Retrospective Machine Learning Approach

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Elderly patients with coexisting coronary artery disease (CAD) and atrial fibrillation (AF) are at significantly increased risk of mortality. Accurate risk stratification is crucial for improving clinical management, yet a dedicated predictive tool for this specific population is lacking. The widely used CHA₂DS₂-VASc score demonstrates limited performance in predicting all-cause mortality in this complex comorbid group. Methods: A cohort of elderly inpatients (≥65 years) diagnosed with CAD and AF were retrospectively enrolled from the Department of Cardiology at the Chinese PLA General Hospital between January 2010 and December 2017. Baseline clinical data during hospitalization were collected, and all patients were followed up for all-cause mortality. Patients were randomly divided into a training set (70%) and a validation set (30%). Variable selection was performed using LASSO-Cox regression. Predictive models were established through a Cox proportional hazards model (via LASSO-Cox) and a random survival forest model to predict all-cause mortality risk. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA), and compared against the CHA₂DS₂-VASc score. Results: A total of 1678 elderly patients with CAD and AF were randomly divided into a training set (n=1174) and a validation set (n=504). Through LASSO‑Cox regression, 17 variables were identified as predictors associated with all‑cause mortality. Two distinct models were developed: LASSO‑Cox Model A included factors such as age, left ventricular ejection fraction, blood glucose, plasma fibrinogen, D‑dimer, prothrombin time, NT‑proBNP, hemoglobin, and hematocrit; LASSO‑Cox Model B incorporated all variables from Model A plus acute myocardial infarction, history of myocardial infarction, renal insufficiency, heart failure, diabetes, stroke, chronic obstructive pulmonary disease, and malignant tumor. The analysis of Cox proportional hazards regression models showed that in the training sets, the Area Under Curves (AUC) of model A, model B and CHA₂DS₂-VASc scores for predicting 1-year all-cause death were 0.83, 0.85 and 0.66, respectively; the AUC for 5-year all-cause death were 0.74, 0.76 and 0.62, respectively. In the validation sets, the AUC of model A, model B and the CHA₂DS₂-VASc score for predicting 1-year all-cause mortality were 0.79, 0.78 and 0.57, respectively; the AUC for 5-year all-cause death were 0.74, 0.75 and 0.57, respectively. Model B demonstrated better calibration and provided greater net clinical benefit in DCA. Conclusion: The LASSO‑Cox machine learning model demonstrates superior predictive performance for all cause mortality relative to the traditional CHA₂DS₂-VASc score in elderly patients with CAD and AF.

Article activity feed